| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.034 | 0.8 |